0001209191-19-060111.txt : 20191211
0001209191-19-060111.hdr.sgml : 20191211
20191211192117
ACCESSION NUMBER: 0001209191-19-060111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191209
FILED AS OF DATE: 20191211
DATE AS OF CHANGE: 20191211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOB LEONARD S
CENTRAL INDEX KEY: 0001049713
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 191280747
MAIL ADDRESS:
STREET 1: C/O INKINE PHARMACEUTICAL COMPANY INC
STREET 2: 425 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-09
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001049713
JACOB LEONARD S
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
0
0
0
Common Stock
2019-12-09
4
M
0
80000
1.60
A
377563
D
Common Stock
2019-12-09
4
S
0
80000
4.6317
D
297563
D
Common Stock
2019-12-09
4
M
0
80000
1.66
A
377563
D
Common Stock
2019-12-09
4
S
0
80000
4.6222
D
297563
D
Common Stock
2019-12-09
4
S
0
84814
4.6317
D
212749
D
Stock Option (right to buy)
1.60
2019-12-09
4
M
0
80000
0.00
D
2011-05-27
2020-05-26
Common Stock
80000
0
D
Stock Option (right to buy)
1.66
2019-12-09
4
M
0
80000
0.00
D
2012-05-17
2021-05-16
Common Stock
80000
0
D
The stock option exercises and sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
/s/Keith Muckenhirn as attorney-in-fact for Leonard S. Jacob
2019-12-11